Literature DB >> 1601752

Predominant pathogens in hospital infections.

W R Jarvis1, W J Martone.   

Abstract

To determine the distribution of pathogens causing nosocomial infections in United States hospitals, we analysed data from the National Nosocomial Infections Surveillance (NNIS) System. From October 1986 to December 1990, amongst hospitals conducting hospital-wide surveillance, the five most commonly reported pathogens were Escherichia coli (13.7%), Staphylococcus aureus (11.2%), enterococci (10.7%), Pseudomonas aeruginosa (10.1%), and coagulase-negative staphylococci (9.7%). The commonest pathogens reported by site included, bloodstream: coagulase-negative staphylococci, S. aureus, enterococci, E. coli, and Candida spp.; lower respiratory tract infection: S. aureus, P. aeruginosa and Enterobacter spp.; surgical wound infection: S. aureus, enterococci and coagulase-negative staphylococci; and urinary tract infection: E. coli, enterococci, and P. aeruginosa. Among hospitals conducting intensive care unit (ICU) surveillance, the commonest pathogens were P. aeruginosa (12.4%), S. aureus (12.3%), coagulase-negative staphylococci (10.2%), Candida spp. (10.1%), Enterobacter spp. and enterococci (8.6% each). In the ICUs, the commonest pathogens found in the bloodstream were coagulase-negative staphylococci, S. aureus, and enterococci; in lower respiratory tract infections P. aeruginosa, S. aureus, and enterococci; in surgical wound infections enterococci, coagulase-negative staphylococci, and Enterobacter spp. and in urinary tract infections Candida spp., E. coli, enterococci, P. aeruginosa, and Enterobacter spp. These data show that S. aureus, E. coli and P. aeruginosa remain important nosocomial pathogens, that coagulase-negative staphylococci, enterococci and C. albicans are pathogens of increasing importance, and that the distribution of pathogens differs by site and hospital location.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601752     DOI: 10.1093/jac/29.suppl_a.19

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  112 in total

Review 1.  Basic aspects of the pathogenesis of staphylococcal polymer-associated infections.

Authors:  C von Eiff; C Heilmann; M Herrmann; G Peters
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Evidence for nasal carriage of methicillin-resistant staphylococci colonizing intravascular devices.

Authors:  N B Frebourg; B Cauliez; J F Lemeland
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target.

Authors:  C Poyart; G Quesne; C Boumaila; P Trieu-Cuot
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Heteroresistance to vancomycin in Enterococcus faecium.

Authors:  M R Alam; S Donabedian; W Brown; J Gordon; J W Chow; M J Zervos; E Hershberger
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group.

Authors:  E Bouza; F Garcia-Garrote; E Cercenado; M Marin; M S Diaz
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  An Update on the Emergence of Glycopeptide Resistance in Enterococci.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

7.  Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.

Authors:  M A Zeitlinger; P Dehghanyar; B X Mayer; B S Schenk; U Neckel; G Heinz; A Georgopoulos; M Müller; C Joukhadar
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

9.  Microbiological profile of lower respiratory tract infections in neurological intensive care unit of a tertiary care center from Central India.

Authors:  Trupti Bajpai; G Shrivastava; G S Bhatambare; A B Deshmukh; V Chitnis
Journal:  J Basic Clin Pharm       Date:  2013-06

Review 10.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.